However, this trial was conducted according to international
Good Clinical Research Practice (GCRP) guidelines and was the largest trial of chitosan to date, with the largest number of follow-up visits and the most outcome measures.
Importantly, intention-to-treat analyses and several sensitivity analyses were used, thus limiting the bias that inevitably results from restricting analysis to data from ‘completers’ only.